Evidence 1
Activity
Activity
5% Hemolysis
Toxicity
>400 µM
Hemolytic
Cytotoxic
5% Hemolysis | >400 | µM | target cell: Rat erythrocytes
Target
Rat erythrocytes
Source & Reference
NA
DBAASP
Design of therapeutically improved analogue of the antimicrobial peptide, indolicidin, using a glycosylation strategy. | Amino Acids | 2019